Maggie Case

DocwireNews

New research published in Cancer Discovery found an HIV drug used in treatment therapies, known as Iamivudine, stops disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer. Past <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136931/">research</a> from the National Center for Biotechnology Information found HIV patients receiving lifelong three-drug anti-retroviral therapy had a notably lower risk of colon, breast, and prostate cancer. Dr. David T. Ting, MD, of the Mass General Cancer Center, theorizes this type of therapy might prevent cancer, recurrence, or turn a metastatic disease into something more chronic like HIV.In preclinical studies, Dr. Ting and his team observed colorectal cancer cells were sensitive to Iamvudine, reducing their movement, and found drug-induced DNA damage and interferon responses&mdash;proving Iamvudine triggered inflammatory responses in tumor cells. The researchers found that 50 percent of a tumor&rsquo;s DNA were made of &ldquo;repetitive elements&rdquo;&mdash;seen in esophagus, lung, and several other types of cancer&mdash;that weren&rsquo;t present in healthy cells. High levels of RNA reproduce in a viral-like cycle known as &ldquo;repeatome,&rdquo; which relies on reverse transcription to move. Dr. Ting theorizes that immunotherapy joined with reverse transcriptase inhibitor therapy might help immune cells become more involved against cancers.Thirty-two patients whose disease had progressed despite four lines of previous cancer treatments were identified. The first nine received a standard HIV-approved dose of Iamvudine and another 23 received a dose that was adjusted to four times the original dose. Just one dose produced significant signs of disease stability, with nine of the 32 patients (28 percent) showing stability or a mixed response.&ldquo;This provides evidence that an HIV drug can be repurposed as an anti-cancer therapy in metastatic cancer patients,&rdquo; Dr. Ting says. &ldquo;We did the trial to see if we could learn something new about the biology of cancer cells and in the process found this unexpected, very encouraging result. Disease stability in a cancer patient population this advanced, with just one single agent, is highly unusual and we are hoping we can soon initiate a larger Phase III study with a three-drug reverse transcriptase inhibitor combination.&rdquo;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Reverse Transcriptase Inhibitors Used in HIV Therapies Stop Disease Progression in Metastatic Colorectal Cancer

Oncology

New research published in Cancer Discovery found an HIV drug used in treatment therapies, known as Iamivudine, stops disease progression in 25 percent of patients with ...

Reverse Transcriptase Inhibitors Used in HIV Therapies Stop Disease Progression in Metastatic

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe